In his podcast interview, Kennedy noted that unnamed "other journals" may also be prevented from publishing NIH research.

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Millions would lose Medicaid coverage. Millions would be left without health insurance. Signing up for health plans on the ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

Lawmakers expressed bipartisan support for reauthorizing an FDA program that helps streamline the process for bringing ...

"Psychological assessments are essential in the management of myasthenia gravis, as the condition is frequently associated ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

Women around the country have been denied emergency abortions for their life-threatening pregnancies after states swiftly ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

Published in the World Allergy Organization Journal, the paper gives several reasons why it's time to move on from Benadryl, ...

President Donald Trump's big bill making its way through Congress will cut taxes by $3.75 trillion but also increase deficits ...